Glover Nicholas 4
4 · Sierra Oncology, Inc. · Filed Feb 27, 2020
Insider Transaction Report
Form 4
Glover Nicholas
DirectorCEO and President
Transactions
- Award
Stock Option (right to buy)
2020-02-25+359,158→ 359,158 totalExercise: $13.31Exp: 2030-02-25→ Common Stock (359,158 underlying)
Footnotes (1)
- [F1]The option vests as to 25% of the total shares on February 25, 2021, and then 2.0833% of the total shares vest monthly thereafter, with 100% of the total shares vested on February 25, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date.